0001857713-21-000001.txt : 20210421 0001857713-21-000001.hdr.sgml : 20210421 20210420203153 ACCESSION NUMBER: 0001857713-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210421 DATE AS OF CHANGE: 20210420 EFFECTIVENESS DATE: 20210421 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RxMP Therapeutics, Inc. CENTRAL INDEX KEY: 0001857713 IRS NUMBER: 823928186 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-396539 FILM NUMBER: 21839249 BUSINESS ADDRESS: STREET 1: 790 N.W. 107TH AVENUE STREET 2: #215 CITY: MIAMI STATE: FL ZIP: 33172 BUSINESS PHONE: 215-872-9055 MAIL ADDRESS: STREET 1: 790 N.W. 107TH AVENUE STREET 2: #215 CITY: MIAMI STATE: FL ZIP: 33172 D 1 primary_doc.xml X0708 D LIVE 0001857713 RxMP Therapeutics, Inc. 790 N.W. 107TH AVENUE #215 MIAMI FL FLORIDA 33172 215-872-9055 FLORIDA RxMP Therapeutics, LLC None Corporation true 2017 Rifat Pamukcu 790 N.W. 107th Avenue #215 Miami FL FLORIDA 33172 Executive Officer Director Promoter Jy Wenche 790 N.W. 107th Avenue #215 Miami FL FLORIDA 33172 Executive Officer Director Promoter Sue Van 790 N.W. 107th Avenue #215 Miami FL FLORIDA 33172 Director Biotechnology Decline to Disclose 06b false 2021-03-31 false true false 10000 3000000 1013023 1986977 true 4 39 0 0 0 false RxMP Therapeutics, Inc. /s/ Rifat Pamukcu Rifat Pamukcu Chief Executive Officer 2021-04-20